WITHDRAWN: The Present Situation of the Quality of Utility Values in the Study of Cost-Utility in China

Author(s)

ABSTRACT WITHDRAWN

OBJECTIVES: To analyze the methods of obtaining HSU data and the quality of reporting HSU data and to report their development trend to make suggestions for future study.

METHODS: A systematic search and selection process was carried out in CNKI, Wanfang and Weipu database to identify all relevant published research. Data was extracted into Excel and results were summarized and reported.

RESULTS: In total, 234 articles and 1 061 HSU were obtained. Most HSUs (n=743, 70.0%) were obtained from published literature. Most of the articles did not conduct a systematic review to obtain HSUs (n=217, 92.7%). In terms of assessment methods, 266 HSUs described the use of the five dimensional health scale (EQ-5D) for measurement, which has shown an upward trend in the past 10 years.

CONCLUSIONS: Most of the articles obtained HSU data from published studies but did not obtain the data through a systematic review. In addition, published articles did not report sufficient information of the HSU used, such as the source of value set, source of HRQoL data, sample size, etc., and the trend continued to grow. Chinese researchers should stick to the Pharmacoeconomics evaluation guideline and pay more attention to the HSU quality used for CUA research, strengthening its preciseness and credibility

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

EE109

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×